Complicaciones hepáticas asociadas al uso de nutrición parenteral

Parenteral nutrition associated liver disease (PNALD) is an important problem in patients who require longterm parenteral nutrition as well as in preterm infants. Prevalence varies according to different series. Clinical presentation is different in adults and infants. Although since its first descriptions several hypothesis have been elucidated, the aetiology is not quite clear. It is possible that different factors could be involved. PNALD risk factors can be classified in three groups: 1) those derived from the lack of enteral nutrition stimulus; 2) parenteral nutrition components acting as toxic or the lack of specific nutrients and 3) those due to the underlying disease. If PNALD appears in short-term PN and it presents only as a mild elevation of liver enzymes, there is no need to treat. On the contrary, when direct bilirubin is > 2 mg/dL and lasts longer, there is a need to consider different causes and to minimize risk factors. We review the different approaches to manage PNALD, including optimizing enteral nutrition, modify parenteral solutions, use of specific nutrients —taurine, choline, etc.— or the use of drugs (mainly ursodeoxicolic acid) If liver disease progresses to a cirrhosis a liver transplant must be considered. (Nutr Hosp. 2008;23:25-33)

[1]  G. Moro,et al.  Ursodeoxycholic Acid Treatment in Preterm Infants: A Pilot Study for the Prevention of Cholestasis Associated With Total Parenteral Nutrition , 2008, Journal of pediatric gastroenterology and nutrition.

[2]  D. Robinson High-Dose Oral Erythromycin Decreased the Incidence of Parenteral Nutrition-Associated Cholestasis in Preterm Infants , 2008 .

[3]  M. Park,et al.  Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? , 2008, European Journal of Pediatrics.

[4]  M. Abecassis,et al.  Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. , 2007, Journal of the American College of Surgeons.

[5]  A. Chawla,et al.  Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams. , 2007, JPEN. Journal of parenteral and enteral nutrition.

[6]  B. Carter,et al.  Intestinal Failure-Associated Liver Disease: Management and Treatment Strategies Past, Present, and Future , 2007, Seminars in liver disease.

[7]  O. Goulet,et al.  Early Central Catheter Infections May Contribute to Hepatic Fibrosis in Children Receiving Long-term Parenteral Nutrition , 2007, Journal of pediatric gastroenterology and nutrition.

[8]  Andrea Laghi,et al.  MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease , 2007, Acta paediatrica.

[9]  J. Burnett,et al.  Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease , 2007, Journal of Perinatology.

[10]  A. Ukleja,et al.  Complications of parenteral nutrition. , 2007, Gastroenterology clinics of North America.

[11]  V. Ng,et al.  The use of conjugated hyperbilirubinemia greater than 100 micromol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. , 2007, Journal of pediatric surgery.

[12]  A. Mesejo,et al.  Liver dysfunction associated with artificial nutrition in critically ill patients , 2007, Critical care.

[13]  N. Barshes,et al.  Isolated orthotopic liver transplantation for parenteral nutrition-associated liver injury. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[14]  B. Stoll,et al.  Total parenteral nutrition induces liver steatosis and apoptosis in neonatal piglets. , 2006, The Journal of nutrition.

[15]  S. Schneider,et al.  Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study , 2006, British Journal of Nutrition.

[16]  J. Folkman,et al.  Reversal of Parenteral Nutrition–Associated Liver Disease in Two Infants With Short Bowel Syndrome Using Parenteral Fish Oil: Implications for Future Management , 2006, Pediatrics.

[17]  Peggy A. Wu,et al.  Parenteral nutrition-associated cholestasis related to parental care. , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[18]  V. Kumpf Parenteral nutrition-associated liver disease in adult and pediatric patients. , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[19]  E. Mascha,et al.  Liver failure is uncommon in adults receiving long-term parenteral nutrition. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[20]  D. Kelly Intestinal failure-associated liver disease: what do we know today? , 2006, Gastroenterology.

[21]  Morton B. Brown,et al.  Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. , 2005, JPEN. Journal of parenteral and enteral nutrition.

[22]  Imad F. Btaiche,et al.  Metabolic complications of parenteral nutrition in adults, Part 2. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[23]  P. Tsao,et al.  Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. , 2004, The Journal of pediatrics.

[24]  R. Ehrenkranz,et al.  Total Parenteral Nutrition induced Liver Pathology: An Autopsy Series of 24 Newborn Cases , 2004, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[25]  A. Buchman Choline deficiency during parenteral nutrition in humans. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[26]  C. Ashley,et al.  Management of complications in patients receiving home parenteral nutrition. , 2003, Gastroenterology.

[27]  N. Klein,et al.  Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates , 2003, European Journal of Clinical Nutrition.

[28]  W. Walker,et al.  Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. , 2003, Advances in pediatrics.

[29]  K. Oien,et al.  Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha. , 2002, Liver.

[30]  Imad F. Btaiche,et al.  Parenteral Nutrition‐Associated Liver Complications in Children , 2002, Pharmacotherapy.

[31]  G. Jensen,et al.  Abnormal liver functions as a result of total parenteral nutrition in a patient with short-bowel syndrome. , 2000, Nutrition.

[32]  T. Hwang,et al.  Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. , 2000, Hepato-gastroenterology.

[33]  S. Kamata,et al.  Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience. , 2000, Journal of pediatric surgery.

[34]  A. Buchman,et al.  Metabolic and nutritional considerations in nonalcoholic fatty liver , 2000, Hepatology.

[35]  M. Rela,et al.  Isolated liver transplant and sequential small bowel transplantation for intestinal failure and related liver disease in children. , 2000, Transplantation.

[36]  C. Degott,et al.  Prevalence of Liver Disease and Contributing Factors in Patients Receiving Home Parenteral Nutrition for Permanent Intestinal Failure , 2000, Annals of Internal Medicine.

[37]  D. Jenden,et al.  Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study. , 1999, JPEN. Journal of parenteral and enteral nutrition.

[38]  S. Suita,et al.  Complications in neonates with short bowel syndrome and long-term parenteral nutrition. , 1999, JPEN. Journal of parenteral and enteral nutrition.

[39]  R. Chesney,et al.  Cysteine supplementation results in normalization of plasma taurine concentrations in children receiving home parenteral nutrition. , 1999, The Journal of pediatrics.

[40]  M. Demircan,et al.  The effects of acetylsalicylic acid, interferon-alpha, and vitamin E on prevention of parenteral nutrition-associated cholestasis: an experimental study. , 1999, Journal of pediatric gastroenterology and nutrition.

[41]  J. M. M. Villares,et al.  Complicaciones hepáticas asociadas a nutrición parenteral de corta duración en niños , 1999 .

[42]  C. Di Lorenzo,et al.  Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. , 1999, Journal of pediatric surgery.

[43]  M. Cadnapaphornchai,et al.  Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. , 1998, Journal of pediatric gastroenterology and nutrition.

[44]  Roger Williams,et al.  Liver Damage in Human Small Intestinal Bacterial Overgrowth , 1998, American Journal of Gastroenterology.

[45]  K. Iyer,et al.  The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. , 1998, Nutrition.

[46]  D. Kelly Liver complications of pediatric parenteral nutrition--epidemiology. , 1998, Nutrition.

[47]  D. Teitelbaum,et al.  Parenteral nutrition-associated cholestasis. , 2001, Seminars in pediatric surgery.

[48]  W. Balistreri Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. , 1997, Journal of pediatric gastroenterology and nutrition.

[49]  K. Georgeson,et al.  Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. , 1997, Journal of pediatric surgery.

[50]  J. Geiger,et al.  Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. , 1997, JPEN. Journal of parenteral and enteral nutrition.

[51]  K. Conner,et al.  40 RESOLUTION OF TPN ASSOCIATED CHOLESTASIS FOLLOWING DISCONTINUATION OF PARENTERAL PROTEIN , 1996 .

[52]  A. Guarino,et al.  Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. , 1996, Gastroenterology.

[53]  N Meadows,et al.  Manganese toxicity in children receiving long-term parenteral nutrition , 1996, The Lancet.

[54]  M. Ament,et al.  Chronic liver disease in children on long‐term parenteral nutrition , 1996, Journal of gastroenterology and hepatology.

[55]  J. Corkery,et al.  Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. , 1996, Journal of pediatric surgery.

[56]  D. Jenden,et al.  Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.

[57]  D. Teitelbaum,et al.  Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide. , 1995, Journal of pediatric surgery.

[58]  J. Shaffer Hepatic complications of parenteral nutrition. , 1995, Clinical nutrition.

[59]  M. Pohjavuori,et al.  Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: a preliminary report. , 1995, Journal of pediatric surgery.

[60]  A. Hofmann Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. , 1995, Journal of pediatric gastroenterology and nutrition.

[61]  J. Raffensperger,et al.  The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition. , 1995, Journal of pediatric surgery.

[62]  P. Malet,et al.  Ursodiol for Hepatobiliary Disorders , 1994, Annals of Internal Medicine.

[63]  F. Iglicki,et al.  Chronic cholestasis associated with long-term parenteral nutrition. , 1994, Transplantation proceedings.

[64]  O. Goulet,et al.  Liver disease associated with long-term parenteral nutrition in children. , 1994, Transplantation proceedings.

[65]  H. Sax Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition. , 1994 .

[66]  J. Fischer,et al.  Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition. , 1994, JPEN. Journal of parenteral and enteral nutrition.

[67]  P. Ingrand,et al.  Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? , 1994, Journal of hepatology.

[68]  P. Holt,et al.  Hepatobiliary complications of total parenteral nutrition. , 1994, Journal of clinical gastroenterology.

[69]  T. Barrioz,et al.  [Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease?]. , 1994, Gastroenterologie clinique et biologique.

[70]  K. Mills,et al.  Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. , 1993, Gastroenterology.

[71]  K. Ephgrave,et al.  Liver dysfunction and energy source: results of a randomized clinical trial. , 1993, JPEN. Journal of parenteral and enteral nutrition.

[72]  R. L. Moss,et al.  Hepatobiliary dysfunction during total parenteral nutrition is caused by infusate, not the route of administration. , 1993, Journal of pediatric surgery.

[73]  J. Raffensperger,et al.  Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study. , 1993, Journal of pediatric surgery.

[74]  D. Heresbach,et al.  Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. , 1992, Nutrition.

[75]  K. Lindor,et al.  Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report. , 1991, Gastroenterology.

[76]  F. Guertin,et al.  Effect of taurine on total parenteral nutrition-associated cholestasis. , 1991, JPEN - Journal of Parenteral and Enteral Nutrition.

[77]  M. Shils,et al.  Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[78]  M. Ball,et al.  Liver function tests in patients receiving parenteral nutrition. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[79]  E. Cabré,et al.  Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[80]  J. Kopple,et al.  Effect of intravenous taurine supplementation on plasma, blood cell, and urine taurine concentrations in adults undergoing long-term parenteral nutrition. , 1990, The American journal of clinical nutrition.

[81]  J. Paauw,et al.  Taurine concentrations in serum of critically injured patients and age- and sex-matched healthy control subjects. , 1990, The American journal of clinical nutrition.

[82]  J. Folkman,et al.  A proposed cause for the hepatic dysfunction associated with parenteral nutrition. , 1990, Journal of pediatric surgery.

[83]  Bove Ke,et al.  Hepatobiliary consequences of parenteral alimentation. , 1990 .

[84]  H. Pitt,et al.  Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. , 1990, Surgery, gynecology & obstetrics.

[85]  Fisher Rl Hepatobiliary abnormalities associated with total parenteral nutrition. , 1989 .

[86]  R. L. Fisher Hepatobiliary abnormalities associated with total parenteral nutrition. , 1989, Gastroenterology clinics of North America.

[87]  H. Sax,et al.  Hepatic complications of total parenteral nutrition. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[88]  B. Wolfe,et al.  Effect of total parenteral nutrition on hepatic histology. , 1988, Archives of surgery.

[89]  C. Degott,et al.  Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations. , 1988, Gastroenterology.

[90]  P. Rosenthal,et al.  CERULETIDE TO TREAT NEONATAL CHOLESTASIS , 1988, The Lancet.

[91]  D. Labarthe,et al.  Total parenteral nutrition-related cholestasis in infants. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[92]  O. Garden,et al.  Intravenous nutrition and hepatic dysfunction. , 1986, JPEN. Journal of parenteral and enteral nutrition.

[93]  R. Merritt Cholestasis associated with total parenteral nutrition. , 1986, Journal of pediatric gastroenterology and nutrition.

[94]  D. Rudman,et al.  Nutrient deficiencies during total parenteral nutrition. , 2009, Nutrition reviews.

[95]  A. Nanji,et al.  Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. , 1985, JPEN. Journal of parenteral and enteral nutrition.

[96]  J. Heckenlively,et al.  Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. , 1985, The New England journal of medicine.

[97]  H. Pitt,et al.  Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. , 1985, Annals of surgery.

[98]  C. Roy,et al.  Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. , 1983, The American journal of clinical nutrition.

[99]  B. Messing,et al.  Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? , 1983, Gastroenterology.

[100]  P. Whitington,et al.  The effect of short-term total parenteral nutrition on hepatic function in the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function. , 1981, The Journal of pediatrics.

[101]  B. Dahms,et al.  Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. , 1981, Gastroenterology.

[102]  K. Jeejeebhoy,et al.  Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. , 1980, Gastroenterology.

[103]  R. Nelson,et al.  Intrahepatic cholestasis associated with parenteral nutrition in premature infants. , 1979, Pediatrics.

[104]  C. Witzleben,et al.  Total parenteral nutrition. , 1971, The Journal of pediatrics.